Kunihiko Tsuji

机构：Teine Keijinkai Hospital · ORCID：0009-0007-4152-9364

发表论文 52 篇 · 总被引 268 次 · h-index 11

代表论文

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study (2025 · Liver International · 被引 8)
Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)
Impact of time‐of‐day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study (2025 · Hepatology Research · 被引 6)
Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real‐World Study (2026 · Hepatology Research · 被引 5)
Comparison of Surgical Resection and Radiofrequency Ablation for Early‐Stage HCC Patients With Child–Pugh Class B (2025 · Journal of Gastroenterology and Hepatology · 被引 5)
Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab (2025 · Hepatology Research · 被引 4)